Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-01-29 Purchase |
2025-01-30 4:02 pm |
Caribou Biosciences Inc. | CRBU | Ryali Sriram Chief Financial Officer |
17,360 | $1.42 | $24,651 | 17,360 (Direct) |
View |
| 2023-09-08 Purchase |
2023-09-12 4:07 pm |
CODEXIS INC. | CDXS | Ryali Sriram Chief Financial Officer |
11,650 | $1.7044 | $19,856 | 123,441 (Direct) |
View |
| 2022-03-14 Sale |
2022-03-14 9:22 pm |
Eiger BioPharmaceuticals Inc. | EIGR | Ryali Sriram Chief Financial Officer |
2,266 | $5.5973 | $12,683 | 41,566 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-10 Option Award |
2025-01-10 5:06 pm |
N/A 2035-01-09 |
Caribou Biosciences Inc. | CRBU | Ryali Sriram Chief Financial Officer |
300,000 | $0 | 300,000 (Direct) |
View |
| 2024-01-01 Option Award |
2024-01-02 9:24 pm |
N/A 2034-01-01 |
CODEXIS INC. | CDXS | Ryali Sriram Chief Financial Officer |
366,475 | $0 | 489,916 (Direct) |
View |
| 2023-02-10 Option Award |
2023-02-14 4:11 pm |
N/A 2033-02-10 |
CODEXIS INC. | CDXS | Ryali Sriram Chief Financial Officer |
484,428 | $0 | 484,428 (Direct) |
View |
| 2022-03-11 Option Award |
2022-03-11 9:06 pm |
N/A 2032-03-10 |
Eiger BioPharmaceuticals Inc. | EIGR | Ryali Sriram Chief Financial Officer |
167,000 | $0 | 186,832 (Direct) |
View |
| 2021-07-29 Option Award |
2021-07-30 4:26 pm |
N/A 2031-07-28 |
Eiger BioPharmaceuticals Inc. | EIGR | Ryali Sriram Chief Financial Officer |
30,000 | $0 | 30,000 (Direct) |
View |
| 2021-05-10 Option Award |
2021-05-11 8:32 pm |
N/A 2031-05-09 |
Eiger BioPharmaceuticals Inc. | EIGR | Ryali Sriram Chief Financial Officer |
87,000 | $0 | 87,000 (Direct) |
View |
| 2021-03-12 Option Award |
2021-03-15 7:38 pm |
N/A 2031-03-11 |
Eiger BioPharmaceuticals Inc. | EIGR | Ryali Sriram Chief Financial Officer |
113,750 | $0 | 115,652 (Direct) |
View |